Small interfering RNAs are naturally occurring RNA molecules that are part of the non-coding RNA family found within cells. CD Formulation offers a comprehensive range of customized siRNA synthesis, including various fluorescent markers and other modifications. Currently, our backbone and base modifications include amino linkers, sulfur linkers, biotin, dabcyl, phosphate, and more.
Based on the analysis of the sequence information, we have established the following rules for the rational design of siRNA.
Fig.1 Rules for the rational design of siRNA. (CD Formulation)
CD Formulation offers customized siRNA synthesis in various quantities tailored to our clients' silencing needs. Upon receiving the siRNA sequences from our clients, our experts promptly configure these sequences using our advanced design tools. All customized nucleic acid molecules are synthesized and manufactured according to rigorous standards and undergo quality control (QC) inspections via HPLC and MS. They are then annealed in RNase-free water and converted into double-stranded form using gel electrophoresis. Furthermore, the final siRNAs are shipped as lyophilized pellets to ensure safety and stability during transport.
Control siRNA is an essential component of comprehensive RNAi experiments, primarily including transfection controls, positive controls, negative controls, and blank controls. These control products assist customers in optimizing siRNA transfection conditions, verifying the accuracy of gene silencing experimental procedures, and conducting specific analyses of siRNA-induced gene silencing effects, ensuring the successful completion of RNAi experiments.
We offer specially designed negative control siRNAs that can be utilized to demonstrate minimal off-target effects through gene chip assays.
We offer positive control siRNAs targeting endogenous genes that have been specifically designed and experimentally validated to confirm the feasibility of the RNA interference (RNAi) process, ensuring the successful execution of RNAi experiments.
Fluorescently labeled targetless siRNAs can be effectively detected using fluorescence imaging systems. We offer Cy3 fluorescently labeled transfection control siRNA that does not require chemical modification. This control can be co-transfected with the target gene siRNA during experiments to assess transfection efficiency. Detection can be performed using fluorescence microscopy, confocal microscopy, or flow cytometry.
Chemical modification of RNA can significantly alter the physicochemical properties of nucleic acids, which in turn affects their function. This includes various end-labeling and intermediate modifications. Common modifications we offer include phosphorothioate backbones, 2'-O-methylation, 2'-O-fluorination, cholesterol conjugation, Cy3 and Cy5 labeling, biotin, amine, DNP, and alkyne modifications, among others.
Fig.2 Flow chart of siRNA preparation. (CD Formulation)
CD Formulation's technology platform offers a wide range of tools and methods essential for the research and application of siRNA in gene silencing. This platform covers all vital processes and techniques involved in the design, synthesis, delivery, and analysis of siRNA. It allows for the production of high-purity siRNA, ensuring its effectiveness and specificity.
Synthesis Technology Platforms |
---|
Solid Phase Synthesis Technology Platform |
Enzymatic Synthesis Technology Platform |
Genetic Engineering Technology Platform |
Technology: siRNA synthesis using chemical modification technologies
Journal: Frontiers in genetics
IF: 3.258
Published: 2012
Results:
siRNAs hold great potential as a new category of therapeutic agents. While more work is needed to develop effective methods for delivering these molecules within the body, researchers have already made progress in designing siRNA molecules with chemical modifications. These modifications help to address early challenges related to targeting specificity, molecule stability, and preventing immune responses. To date, a large number of siRNA structures and chemical modification types are available to facilitate siRNA-mediated gene silencing in vivo, making the choice of design and modification type challenging for individual experimenters.
Fig.3 The benefits and limitations of synthetic siRNA application. (Bramsen J B, et al., 2012)
CD Formulation offers customized siRNA services, including the design and synthesis of siRNA targeting specific gene targets to achieve effective gene silencing. The service process covers siRNA sequence design, chemical synthesis, quality control, and functional validation to ensure that the provided siRNA has efficient and specific gene knockdown effects. Contact us for professional solutions tailored to your needs.
References